| Literature DB >> 35698056 |
Ramyaa Srinivasan1, Michel M Teussink2, Kenneth R Sloan3, Rekha Priya Kalluri Bharat1, Raja Narayanan4, Rajiv Raman5.
Abstract
BACKGROUND: To estimate macular pigment values in macular telangiectasia (MacTel) Type 2 in comparison with healthy subjects in the South Indian population across different spatial profiles and to quantify the regional differences of macular pigment optical density (MPOD) in MacTel Type 2.Entities:
Keywords: Macular pigment; Dual-wavelength autofluorescence; Macular telangiectasia type 2; OCT features; Visual acuity
Mesh:
Substances:
Year: 2022 PMID: 35698056 PMCID: PMC9195394 DOI: 10.1186/s12886-022-02483-y
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.086
Fig. 1Example of the grayscale/ colourized image of a MacTel Type 2 subject, used to measure MPOD in two different regions (b—peripheral region & c—central region)
Demographic details of the study subjects
| Parameter | Healthy controls | MacTel Type 2 subjects | |
|---|---|---|---|
| Subjects enrolled (n) | 31 (60 eyes) | 22 (41 eyes) | - |
| Gender | |||
| Male, n (%) | 12 (38.70%) | 4 (18.18%) | |
| Female, n (%) | 19 (61.29%) | 18 (81.81%) | 0.637 |
| Age (years), mean ± SD (range) | 39.10 ± 12.74 (21–65) | 58.09 ± 10.19 (36–78) | |
| Race (%) | South Indian ethnicity (100%) | South Indian ethnicity (100%) | - |
| aBCVA, Snellen equivalent, median (range) | 20/20 (20/20—20/20) | 20/80 (20/600—20/20) | - |
| Refractive error (range) | -3.0 0DS to + 2.0 0DS | -4.0 0DS to + 2.5 0DS | - |
| Lens status, phakic/ pseudophakic (n) | 57/ 3 | 29/ 12 | - |
aBCVA—Best corrected visual acuity
Macular pigment optical density at 1°, 2°, and 6° foveal eccentricity
| Variable | Radius Eccentricity | Healthy subjects | MacTel Type 2 subjects | |
|---|---|---|---|---|
Mean aMPOD (d.u.) | 1 | 0.38 ± 0.11 | -0.109 ± 0.14 | |
| 2 | 0.23 ± 0.08 | -0.11 ± 0.11 | ||
| 6 | 0.06 ± 0.03 | -0.001 ± 0.02 | ||
Mean bMPOV (d.u.d2) | 1 | 792.25 ± 210.18 | -211.63 ± 223.42 | |
| 2 | 2024.79 ± 670.60 | -879.88 ± 795.26 | ||
| 6 | 4380.45 ± 1913.34 | -4088.23 ± 3676.59 |
aMPOD—Macular pigment optical density
bMPOV—Macular pigment optical volume
Fig. 2A and B Comparison of mean MPOD along the ETDRS grid between healthy controls (A) and MacTel type 2 subjects (B) C and D Comparison of mean MPOD along the 30° radial sectors between healthy controls (C) and MacTel type 2 subjects (D)(Values denoted in yellow color shows statistically significant difference of P < 0.05)
Fig. 3The mean MPOD and MPOV at 1°, 2° and 6° radial eccentricities in MacTel. Type 2 subjects along the clearly identifiable patterns in 8 different sectors (A—nasal, B—nasal upper, C—upper, D—temporal upper, E—temporal, F—temporal lower, G—lower and H—nasal lower)
Macular pigment optical density in central and peripheral regions in different stages of MacTel type 2
| a | ||||||
|---|---|---|---|---|---|---|
| Stages 2 and 3 | ||||||
| Peripheral region | 0.04 | 0.01 | 0.04 | 0.02 | 0.08 | |
| Central region | -0.02 | 0.03 | -0.02 | -0.09 | 0.06 | |
| Stages 4 and 5 | ||||||
| Peripheral region | 0.07 | 0.12 | 0.04 | -0.002 | 0.49 | 0.449 |
| Central region | 0.02 | 0.25 | -0.05 | -0.14 | 1.00 | |
| Peripheral region | ||||||
| Stages 2 and 3 | 0.04 | 0.01 | 0.04 | 0.02 | 0.08 | |
| Stages 4 and 5 | 0.07 | 0.12 | 0.04 | -0.002 | 0.49 | |
| Central region | ||||||
| Stages 2 and 3 | -0.02 | 0.03 | -0.02 | -0.09 | 0.06 | |
| Stages 4 and 5 | 0.02 | 0.25 | -0.05 | -0.14 | 1.00 | |
aMPOD—Macular pigment optical density
OCT features and corresponding mean MPOD in peripheral and central region of MacTel type 2 subjects
| a | Peripheral | Central | |||
|---|---|---|---|---|---|
| Blunting of foveal pit | |||||
| Present | 6 | 0.05 | 0.311 | -0.04 | 0.703 |
| Absent | 35 | 0.06 | 0.009 | ||
| Inner retinal cavities | |||||
| Present | 23 | 0.04 | 0.471 | -0.04 | |
| Absent | 18 | 0.08 | 0.06 | ||
| Outer retinal cavities | |||||
| Present | 17 | 0.05 | 0.068 | -0.03 | 0.206 |
| Absent | 24 | 0.06 | 0.01 | ||
| cILM draping | |||||
| Present | 3 | 0.06 | 0.497 | -0.03 | 0.896 |
| Absent | 38 | 0.06 | 0.001 | ||
| Intraretinal hyperreflective lesions | |||||
| Present | 23 | 0.05 | 0.582 | 0.02 | 0.572 |
| Absent | 18 | 0.07 | -0.03 | ||
| dEZ disruption | |||||
| Present | 35 | 0.06 | 0.164 | -0.002 | |
| Absent | 6 | 0.06 | 0.006 | ||
| Foveal thinning | |||||
| Present | 15 | 0.06 | 0.349 | 0.03 | 0.891 |
| Absent | 26 | 0.05 | -0.02 | ||
| eSRNV | |||||
| Present | 6 | 0.16 | 0.349 | -0.03 | 0.071 |
| Absent | 35 | 0.04 | 0.003 | ||
| fLMH | |||||
| Present | 1 | 0.03 | 0.667 | -0.06 | 0.595 |
| Absent | 40 | 0.06 | 0.0002 | ||
aOCT—Optical coherence topography
bMPOD—Macular pigment optical density
cILM—Internal limiting membrane
dEZ—Ellipsoid zone
eSRNV—Subretinal neovascularization
fLMH—Lamellar macular hole, Test done: Mann–Whitney U test